FDA inspection
Watson Laboratories Inc: FDA inspection ending Jul 12, 2000
FDA inspection 31184 · No Action Indicated (NAI) · Cincinnati, OH
Key facts
| Inspection ID | 31184 |
|---|---|
| Firm | Watson Laboratories Inc |
| FEI number | 1000515349 |
| Address | 8606 Reading Rd |
| City | Cincinnati |
| State | OH |
| ZIP | 45215-5523 |
| Fiscal year | 2000 |
| Inspection end date | Jul 12, 2000 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data